Australia markets close in 53 minutes

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6270-0.0256 (-3.92%)
At close: 04:00PM EST
0.6201 -0.01 (-1.10%)
After hours: 07:16PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 51.17M
Enterprise value 23.55M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.53
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.74

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-65.99%
S&P500 52-week change 324.55%
52-week high 33.3600
52-week low 30.6200
50-day moving average 30.8023
200-day moving average 31.1225

Share statistics

Avg vol (3-month) 3315.23k
Avg vol (10-day) 3254.18k
Shares outstanding 579.81M
Implied shares outstanding 6N/A
Float 847.95M
% held by insiders 122.06%
% held by institutions 136.80%
Shares short (14 Nov 2021) 41.41M
Short ratio (14 Nov 2021) 47.2
Short % of float (14 Nov 2021) 42.70%
Short % of shares outstanding (14 Nov 2021) 41.76%
Shares short (prior month 14 Oct 2021) 41.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Oct 2017
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 305 Oct 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-36.89%
Return on equity (ttm)-90.70%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -31.79M
Net income avi to common (ttm)-30.93M
Diluted EPS (ttm)-0.3880
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.18M
Total cash per share (mrq)0.35
Total debt (mrq)564k
Total debt/equity (mrq)2.79
Current ratio (mrq)3.19
Book value per share (mrq)0.25

Cash flow statement

Operating cash flow (ttm)-27.77M
Levered free cash flow (ttm)-15.27M